Adaptive Biotechnologies
ADPT
ADPT
223 hedge funds and large institutions have $1.01B invested in Adaptive Biotechnologies in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 84 increasing their positions, 72 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1.16% more ownership
Funds ownership: 91.68% → 92.84% (+1.2%)
0% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 27
1% less funds holding
Funds holding: 226 → 223 (-3)
Holders
223
Holding in Top 10
3
Calls
$11.6M
Puts
$358K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$3.93M | |
| 3 | +$3.91M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$3.62M |
| 5 |
Barclays
London,
United Kingdom
|
+$3.36M |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$4.64M | |
| 3 | -$4.35M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.56M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$2.44M |